The US Food and Drug Administration on Monday expanded the emergency use authorization for Pfizer's Covid-19 vaccine boosters to children ages 12 to 15.
The post CDC backs FDA's decision to reduce time between primary series and booster dose of Pfizer's Covid-19 vaccine appeared first on The Atlanta Voice.
